Highlights
1 patent
About
Early Diagnosis and Treatment of Lung Cancer
W Endoluminal Robotics is developing a solution for the early diagnosis and treatment of lung cancer. Its novel mechanical solution and advanced control algorithms enable limitless accessibility to every location within the lungs, with true live confirmation.
The company’s technology is revolutionizing diagnostics by increasing certainty in lung biopsies and enabling advanced lung treatment solutions, offering an innovative approach designed to surpass other advanced technologies while reducing the burden on hospitals.
Identity
| Name | W Endoluminal Robotics |
|---|---|
| Slug | w-endoluminal-robotics-1 |
| Former names | AMT |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NuzrIkJDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ address | Israel |
Web & social
| https://www.linkedin.com/company/95952247 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Machinery & Robotics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
diagnosticsminimally-invasivebiopsymedical-devicesroboticssurgerymedical-technologiescancer
Funding
| Total raised | $260K |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}